VRTX Competitors & Alternatives
Compare Vertex Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
VRTX
Main Stock$453.06
Tradestie Score
67
Market Cap
$103.64B
P/E Ratio
25.8
Revenue Growth
0.1%
Analyst Upside
+21.3%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$719.88
|
$63.59B | 17.4 | 59 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$291.48
|
$60.38B | 71.4 | 54 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$802.70
|
$46.96B | 36.1 | 55 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$316.55
|
$36.81B | 71.4 | 59 | Compare |
|
INSM
Insmed, Inc.
|
$117.99
|
$31.13B | - | 45 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$92.23
|
$24.57B | - | 54 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$204.53
|
$22.61B | 22.1 | 64 | Compare |
|
GMAB
Genmab A/S ADS
|
$26.55
|
$19.56B | 20.7 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$98.82
|
$16.93B | 14.2 | 64 | Compare |
|
ILMN
Illumina Inc
|
$145.00
|
$15.72B | 26.4 | 59 | Compare |
More VRTX Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry